Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Nuclear Medicine

Free Subscription Articles published in Brain Retrieve available abstracts of 57 articles: HTML format

Single Articles

April 2024
1. WANG YT, Therriault J, Servaes S, Tissot C, et al
   Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
   Brain. 2024;147:1497-1510.
   PubMed     Abstract available
   
   
   March 2024
2. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
   Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
   Brain. 2024;147:936-948.
   PubMed     Abstract available
   
   
   December 2023
3. SCHUMACHER J, Kanel P, Dyrba M, Storch A, et al
   Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
   Brain. 2023;146:4964-4973.
   PubMed     Abstract available
   
   
   November 2023
4. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
   Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
   Brain. 2023;146:4520-4531.
   PubMed     Abstract available
   
   
   October 2023
5. LAURENCIN C, Lancelot S, Brosse S, Merida I, et al
   Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
   Brain. 2023 Oct 3:awad338. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2023
6. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
   Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
   Brain. 2023;146:3719-3734.
   PubMed     Abstract available
   
   
   
7. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
   Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
   Brain. 2023;146:3735-3746.
   PubMed     Abstract available
   
   
   August 2023
8. KOSHIMORI Y, Cusimano MD, Vieira EL, Rusjan PM, et al
   Astrogliosis marker 11C-SL2511.88 PET in traumatic brain injury with persistent symptoms.
   Brain. 2023 Aug 21:awad279. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. WUESTEFELD A, Pichet Binette A, Berron D, Spotorno N, et al
   Age-related and amyloid-beta-independent tau deposition and its downstream effects.
   Brain. 2023;146:3192-3205.
   PubMed     Abstract available
   
   
   July 2023
10. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
11. THERRIAULT J, Grothe MJ
    Towards in vivo PET imaging of primary age-related tauopathy.
    Brain. 2023 Jun 16:awad210. doi: 10.1093.
    PubMed    
    
    
    
12. SCHOONHOVEN DN, Coomans EM, Millan AP, van Nifterick AM, et al
    Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study.
    Brain. 2023 Jun 5:awad189. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2023
13. NAM MH, Ko HY, Kim D, Lee S, et al
    Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
    Brain. 2023 Apr 17:awad037. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
14. JACK CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, et al
    Predicting amyloid PET and tau PET stages with plasma biomarkers.
    Brain. 2023 Feb 15:awad042. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. FLORIAN H, Wang D, Arnold SE, Boada M, et al
    Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study.
    Brain. 2023 Feb 2:awad024. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2023
16. MENG Y, Goubran M, Rabin JS, McSweeney M, et al
    Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
    Brain. 2023 Jan 25:awac459. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. VAN ARENDONK J, Neitzel J, Steketee RME, van Assema DME, et al
    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
    Brain. 2023;146:337-348.
    PubMed     Abstract available
    
    
    
18. KATSUMI Y, Putcha D, Eckbo R, Wong B, et al
    Anterior dorsal attention network tau drives visual attention deficits in posterior cortical atrophy.
    Brain. 2023;146:295-306.
    PubMed     Abstract available
    
    
    December 2022
19. PERANI D
    The impact of integrated brain molecular PET measures on DLB cognitive phenotype and clinical course.
    Brain. 2022;145:4157-4159.
    PubMed    
    
    
    
20. YOO HS, Jeong SH, Oh KT, Lee S, et al
    Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
    Brain. 2022;145:4448-4458.
    PubMed     Abstract available
    
    
    November 2022
21. TSAGKARIS S, Yau EKC, McClelland V, Papandreou A, et al
    Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia.
    Brain. 2022 Nov 29:awac439. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. VAN DER WEIJDEN CWJ, Biondetti E, Gutmann IW, Dijkstra H, et al
    Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status.
    Brain. 2022 Nov 21:awac436. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. BETTHAUSER TJ, Bilgel M, Koscik RL, Jedynak BM, et al
    Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts.
    Brain. 2022;145:4065-4079.
    PubMed     Abstract available
    
    
    September 2022
24. SPOTORNO N, Strandberg O, Vis G, Stomrud E, et al
    Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.
    Brain. 2022 Sep 21. pii: 6710203. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. GROOT C, Smith R, Stomrud E, Binette AP, et al
    Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
    Brain. 2022 Sep 9. pii: 6695020. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
26. INSEL PS, Young CB, Aisen PS, Johnson KA, et al
    Tau positron emission tomography in preclinical Alzheimer's disease.
    Brain. 2022 Aug 13. pii: 6665667. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2022
28. LONG JM, Coble DW, Xiong C, Schindler SE, et al
    Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
    Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2022
29. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
30. ALSHELH Z, Brusaferri L, Saha A, Morrissey E, et al
    Neuroimmune signatures in chronic low back pain subtypes.
    Brain. 2022;145:1098-1110.
    PubMed     Abstract available
    
    
    February 2022
31. ANG YS, Cusin C, Petibon Y, Dillon DG, et al
    A multi-pronged investigation of option generation using depression, PET and modafinil.
    Brain. 2022 Feb 12. pii: 6527662. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2022
32. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. COOMANS EM, Tomassen J, Ossenkoppele R, Golla SSV, et al
    Genetically identical twins show comparable tau PET load and spatial distribution.
    Brain. 2022 Jan 12. pii: 6504924. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
34. REINARTZ M, Gabel S, Schaeverbeke J, Meersmans K, et al
    Changes in the language system as amyloid-beta accumulates.
    Brain. 2021;144:3756-3768.
    PubMed     Abstract available
    
    
    
35. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    PubMed     Abstract available
    
    
    
37. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    PubMed     Abstract available
    
    
    
38. HERMANIDES J, Hong YT, Trivedi M, Outtrim J, et al
    Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury.
    Brain. 2021;144:3492-3504.
    PubMed     Abstract available
    
    
    November 2021
39. YAN S, Zheng C, Paranjpe MD, Li Y, et al
    Sex modifies APOE epsilon4 dose effect on brain tau deposition in cognitively impaired individuals.
    Brain. 2021;144:3201-3211.
    PubMed     Abstract available
    
    
    October 2021
40. DOPPLER CEJ, Kinnerup MB, Brune C, Farrher E, et al
    Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Brain. 2021;144:2732-2744.
    PubMed     Abstract available
    
    
    
41. BERRON D, Vogel JW, Insel PS, Pereira JB, et al
    Early stages of tau pathology and its associations with functional connectivity, atrophy and memory.
    Brain. 2021;144:2771-2783.
    PubMed     Abstract available
    
    
    
42. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2021
44. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
46. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2021
47. WALSH J, Tozer DJ, Sari H, Hong YT, et al
    Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Brain. 2021;144:1361-1371.
    PubMed     Abstract available
    
    
    
48. ZHOU L, Li G, Zhang Y, Zhang M, et al
    Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Brain. 2021;144:1488-1497.
    PubMed     Abstract available
    
    
    
49. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2021
50. HOSP JA, Dressing A, Blazhenets G, Bormann T, et al
    Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19.
    Brain. 2021;144:1263-1276.
    PubMed     Abstract available
    
    
    April 2021
51. MAZERE J, Dilharreguy B, Catheline G, Vidailhet M, et al
    Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia.
    Brain. 2021;144:909-923.
    PubMed     Abstract available
    
    
    
52. 
    Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    PubMed    
    
    
    
53. PASCUAL B, Funk Q, Zanotti-Fregonara P, Cykowski MD, et al
    Neuroinflammation is highest in areas of disease progression in semantic dementia.
    Brain. 2021 Apr 6. pii: 6213358. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2021
54. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2021
55. ARNALDI D, Chincarini A, Hu MT, Sonka K, et al
    Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Brain. 2021;144:278-287.
    PubMed     Abstract available
    
    
    December 2020
56. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2020
57. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.